Drugs for Learning Disability (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 52)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Dopamine |
Approved |
Phase 4 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
2 |
|
Aripiprazole |
Approved, Investigational |
Phase 4 |
|
129722-12-9 |
60795 |
Synonyms:
7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone
Abilify
ABILIFY MAINTENA
ABILIFY MAINTENA KIT
ABILIFY MYCITE KIT
Abilify®|Aripiprex®|Aristada® (aripiprazole lauroxil)|OPC 14597|OPC-14597
Abilitat
Aripiprazol
|
ARIPIPRAZOLE
Aripiprazolum
ARIPIPREX
OPC 14597
OPC 31
OPC-14597
OPC-31
|
|
3 |
|
Inositol |
Approved, Investigational, Withdrawn |
Phase 4 |
|
87-89-8 |
|
Synonyms:
(1R,2R,3S,4S,5R,6S)-Cyclohexane-1,2,3,4,5,6-hexol
1,2,3,4,5,6-HEXAHYDROXY-cyclohexane
1,2,3,5/4,6-cyclohexanehexol
1D-Myo-inositol
1l-Myo-inositol
Bios I
cis-1,2,3,5-trans-4,6-cyclohexanehexol
CYCLOHEXANEHEXOL
Cyclohexitol
Dambose
D-Myo-inositol
I-inositol
Inosital
Inosite
Inositol
Ins
|
Iso-inositol
L-myo-Inositol
Meat sugar
meso-Inositol
MI
Myo inositol
Myoinosite
myo-inositol
Myoinositol
NSC-25142
NSC-404118
NSC-55551
NSC-8101
Phaseomannite
Rat antispectacled eye factor
Vitamin b8
|
|
4 |
|
Acetylcysteine |
Approved, Investigational |
Phase 4 |
|
616-91-1 |
581 12035 |
Synonyms:
(2R)-2-ACETAMIDO-3-SULFANYLPROPANOIC ACID
(2R)-2-Acetylamino-3-sulfanylpropanoate
(2R)-2-Acetylamino-3-sulfanylpropanoic acid
(2R)-2-Acetylamino-3-sulphanylpropanoate
(2R)-2-Acetylamino-3-sulphanylpropanoic acid
(R)-2-Acetylamino-3-mercaptopropanoate
(R)-2-Acetylamino-3-mercaptopropanoic acid
(R)-Mercaptate
(R)-Mercaptic acid
(R)-Mercapturic acid
2-[(1-Hydroxyethylidene)amino]-3-sulfanylpropanoate
2-[(1-Hydroxyethylidene)amino]-3-sulphanylpropanoate
2-[(1-Hydroxyethylidene)amino]-3-sulphanylpropanoic acid
2-acetylamino-3-mercapto-Propionate
2-acetylamino-3-mercapto-Propionic acid
5052
Ac pharma brand OF acetylcysteine
ACC
ACC-600
Acebraus
Acemuc
Acetabs
Acetadote
Acetilcisteina
Acetylcystein al
Acetylcystein atid
Acetylcystein heumann
Acetylcystein trom
Acetylcystein, mentopin
Acetylcysteine
Acetylcysteine ac-pharma brand
Acetylcysteine alcon brand
Acetylcysteine aluid brand
Acetylcysteine atid brand
Acetylcysteine azupharma brand
Acetylcysteine betapharm brand
Acetylcysteine bioiberica brand
Acetylcysteine bouchara brand
Acetylcysteine centrafarm brand
Acetylcysteine disphar brand
Acetylcysteine farmasan brand
Acetylcysteine fresenius brand
Acetylcysteine génévrier brand
Acétylcystéine GNR
Acetylcysteine GNR-pharma brand
Acetylcysteine guerbet brand
Acetylcysteine hermes brand
Acetylcysteine heumann brand
Acetylcysteine hydrochloride
Acetylcysteine inpharzam brand
Acetylcysteine intra brand
Acetylcysteine klinge brand
Acetylcysteine krewel brand
Acetylcysteine lichtenstein brand
Acetylcysteine lindopharm brand
Acetylcysteine merck brand
Acetylcysteine oberlin brand
Acetylcysteine pfleger brand
Acetylcysteine pharbita brand
Acetylcysteine roberts brand
Acetylcysteine sodium
Acetylcysteine temmler brand
Acetylcysteine teva brand
Acetylcysteine thiemann brand
Acetylcysteine trommsdorff brand
Acetylcysteine upsa brand
Acetylcysteine whitehall brand
Acetylcysteine zambon brand
Acetylcysteine zinc
Acetylcysteine zyma brand
Acetylcysteine, (D)-isomer
Acetylcysteine, (DL)-isomer
Acetylcysteine, monoammonium salt
Acetylcysteine, monosodium salt
Acetylcysteinum
Acetylin
Acetyst
Acid, mercapturic
Ac-pharma brand OF acetylcysteine
A-CYS
Airbron
Alcon brand OF acetylcysteine
Allen and hanburys brand OF acetylcysteine
Aluid brand OF acetylcysteine
Alveolex
Atid brand OF acetylcysteine
Azubronchin
Azupharma brand OF acetylcysteine
Betapharm brand OF acetylcysteine
Bioiberica brand OF acetylcysteine
Bisolvon nac
Boehringer ingelheim brand OF acetylcysteine
Bouchara brand OF acetylcysteine
Bristol myers squibb brand OF acetylcysteine
Bristol myers squibb brand OF acetylcysteine sodium salt
Bristol-myers squibb brand OF acetylcysteine
Bristol-myers squibb brand OF acetylcysteine sodium salt
Bromuc
broncho Fips
broncho-Fips
BronchoFips
Broncholysin
Broncoclar
Centrafarm brand OF acetylcysteine
CETYLEV
Codotussyl
Cystamucil
dampo Mucopect
|
Dey brand OF acetylcysteine sodium salt
Disphar brand OF acetylcysteine
Durabronchal
EN-CYS
Eurespiran
Exomuc
Fabrol
Farmasan brand OF acetylcysteine
Fluimicil infantil
Fluimucetin
Fluimucil
FLUIMUCIL 600
FLUIMUCIL LONG
FLUIMUCIL N
Flumucetin
Fluprowit
Frekatuss
Fresenius brand OF acetylcysteine
Genac
Génévrier brand OF acetylcysteine
GNR Pharma brand OF acetylcysteine
GNR-Pharma brand OF acetylcysteine
Guerbet brand OF acetylcysteine
Hermes brand OF acetylcysteine
Heumann brand OF acetylcysteine
Hoestil
Hustengetränk, optipect
Hydrochloride, acetylcysteine
Ilube
Inpharzam brand OF acetylcysteine
Intra brand OF acetylcysteine
Jenacystein
Jenapharm
Klinge brand OF acetylcysteine
Krewel brand OF acetylcysteine
L-a-Acetamido-b-mercaptopropionate
L-a-Acetamido-b-mercaptopropionic acid
L-Acetylcysteine
L-alpha-Acetamido-beta-mercaptopropionate
L-alpha-Acetamido-beta-mercaptopropionic acid
Lantamed
Larylin nac
Lichtenstein brand OF acetylcysteine
Lindocetyl
Lindopharm brand OF acetylcysteine
Lysox
L-Α-acetamido-β-mercaptopropionate
L-Α-acetamido-β-mercaptopropionic acid
m Pectil
Mentopin acetylcystein
Mercaptate
Mercaptic acid
Mercapturic acid
Merck brand OF acetylcysteine
Monoammonium salt acetylcysteine
Monosodium salt acetylcysteine
m-Pectil
MPectil
Muciteran
muco Sanigen
Mucolysin
Mucomyst
Mucopect, dampo
Mucosil
MUCOSIL-10
MUCOSIL-20
Mucosol
Mucosolvin
N Acetyl L cysteine
N Acetylcysteine
NAC
NAC al
NAC zambon
NAC, bisolvon
N-Acetyl-3-mercaptoalanine
N-Acetylcysteine
N-Acety-L-cysteine
N-Acetyl-L-(+)-cysteine
N-Acetyl-L-cysteine
NSC-111180
Oberlin brand OF acetylcysteine
Optipect hustengetränk
ORONAC 600
PARVOLEX
Pfleger brand OF acetylcysteine
Pharbita brand OF acetylcysteine
Produpharm lappe brand OF acetylcysteine
RESPI-NAC
Roberts brand OF acetylcysteine
Roche nicholas brand OF acetylcysteine
Sanigen, muco
Siccoral
Siran
Sodium 2-acetamido-3-mercaptopropionate
Sodium, acetylcysteine
Solmucol
Temmler brand OF acetylcysteine
Teva brand OF acetylcysteine
Thiemann brand OF acetylcysteine
Trommsdorff brand OF acetylcysteine
UPSA brand OF acetylcysteine
Whitehall brand OF acetylcysteine
YOURNAC
Zambon brand OF acetylcysteine
Zambon, nac
Zinc, acetylcysteine
Zyma brand OF acetylcysteine
|
|
5 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)FORMAMIDO]PENTANEDIOIC ACID
(2S)-2-[[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]-OXO-METHYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]GLUTARIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID
[<sup>3</sup>H]-folic acid
Acide folique
ácido fólico
Acidum folicum
ACIFOLIC
Apo-Folic
B03BB01
b9, Vitamin
BIO SCIENCE
CYTOFOL
DOSFOLAT B ACTIV
FOLACID
FOLACIN
FOLATE
FOLBAL
FOLCIDIN
FOLDINE
FOLETTES
FOLIAMIN
FOLIC ACID
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
FOLICARE
FOLICET
FOLIPAC
|
FOLSAEURE
FOLSAN
FOLSAURE
Folsäure
FOLSAV
FOLVITE
Folvron
INCAFOLIC
LEXPEC
LIVER LACTOBACILLUS CASEI FACTOR
MILLAFOL
N-(4-{[(2-AMINO-4-OXO-3,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)-L-GLUTAMIC ACID
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)CARBONYL]-L-GLUTAMIC ACID
N-[4-[[(2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL]AMINO]BENZOYL]-L-GLUTAMIC ACID
NATUR FLOW
N-Pteroyl-L-glutamate
N-PTEROYL-L-GLUTAMIC ACID
NSC-3073
PGA
PRECONCEIVE
PTEGLU
PTEROYLGLUTAMATE
PTEROYLGLUTAMIC ACID
PTEROYL-L-GLUTAMATE
PTEROYL-L-GLUTAMIC ACID
PTEROYL-L-MONOGLUTAMATE
PTEROYL-L-MONOGLUTAMIC ACID
PTEROYLMONOGLUTAMIC ACID
ROCHE
Vitamin B9
VITAMIN BC
VITAMIN BE
VITAMIN M
|
|
6 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
7 |
|
Dopamine Agents |
|
Phase 4 |
|
|
|
8 |
|
Antipsychotic Agents |
|
Phase 4 |
|
|
|
9 |
|
Dopamine Antagonists |
|
Phase 4 |
|
|
|
10 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
11 |
|
Dopamine agonists |
|
Phase 4 |
|
|
|
12 |
|
Antidepressive Agents |
|
Phase 4 |
|
|
|
13 |
|
Serotonin Receptor Agonists |
|
Phase 4 |
|
|
|
14 |
|
Serotonin 5-HT1 Receptor Agonists |
|
Phase 4 |
|
|
|
15 |
|
Vitamins |
|
Phase 4 |
|
|
|
16 |
|
Folate |
|
Phase 4 |
|
|
|
17 |
|
Antiviral Agents |
|
Phase 4 |
|
|
|
18 |
|
Vitamin B9 |
|
Phase 4 |
|
|
|
19 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
20 |
|
Trace Elements |
|
Phase 4 |
|
|
|
21 |
|
Vitamin B Complex |
|
Phase 4 |
|
|
|
22 |
|
Expectorants |
|
Phase 4 |
|
|
|
23 |
|
Antidotes |
|
Phase 4 |
|
|
|
24 |
|
N-monoacetylcystine |
|
Phase 4 |
|
|
|
25 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
26 |
|
Omega 3 Fatty Acid |
|
Phase 4 |
|
|
|
27 |
|
Antioxidants |
|
Phase 4 |
|
|
|
28 |
|
Micronutrients |
|
Phase 4 |
|
|
|
29 |
|
Protective Agents |
|
Phase 4 |
|
|
|
30 |
|
Serotonin |
Investigational, Nutraceutical |
Phase 4 |
|
50-67-9 |
5202 |
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5 Hydroxytryptamine
5-HT
5-HT|serotonin
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
5-Hydroxy-tryptamine
|
Antemovis
DS Substance
Enteramin
Enteramine
Hippophaine
Hydroxytryptamine
SEROTONIN
Serotonine
sérotonine
Thrombocytin
Thrombotonin
|
|
31 |
|
Risperidone |
Approved, Investigational |
Phase 3 |
|
106266-06-2 |
5073 |
Synonyms:
Belivon
Buspirone
Consta, risperdal
LY03004
LY-03004
N05AX08
Okedi®|R-64-766|R-64766|Risperdal®
PERSERIS KIT
R-64,766
R-64766
R-64-766
RCN3028
RCN-3028
Rispen
Risperdal
Risperdal consta
RISPERDAL CONSTA LONG ACTING
|
RISPERDAL M
Risperdal m-tab
RISPERDAL QUICKLET
RISPERDONE
Risperidal
Risperidal M-Tab
Risperidona
Risperidona [Spanish]
Risperidone
Rispéridone
Risperidonum
Risperidonum [Latin]
Risperin
Rispolept
Rispolin
Sequinan
Spiron
|
|
32 |
|
Memantine |
Approved, Investigational |
Phase 3 |
|
41100-52-1, 19982-08-2 |
4054 |
Synonyms:
1,3-Dimethyl-5-adamantanamine
1,3-Dimethyl-5-aminoadamantane
1,3-DIMETHYLAMINOADAMANTANE
1-Amino-3,5-dimethyladamantane
3,5-Dimethyl-1-adamantanamine
3,5-Dimethyl-1-aminoadamantane
3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine
AKATINOL
Axura
Axura®|Ebixa®|Namenda®
D-145
DMAA
DRG-0267
Ebixa
Exiba
FP-01
Lundbeck brand OF memantine hydrochloride
|
MARIXINO
Memantin
Memantina
Memantina [INN-Spanish]
MEMANTINE
Memantine [INN]
MEMANTINE HCL
Memantine hydrochloride
Memantinum
Memantinum [INN-Latin]
Merz brand OF memantine hydrochloride
Namenda
NAMENDA XR
NEMDATINE
NSC-102290
SUN-Y7017
VALIOS
|
|
33 |
|
Antiparkinson Agents |
|
Phase 3 |
|
|
|
34 |
|
Excitatory Amino Acid Antagonists |
|
Phase 3 |
|
|
|
35 |
|
Lovastatin |
Approved, Investigational |
Phase 2 |
|
75330-75-5 |
53232 |
Synonyms:
(+)-mevinolin|6α-methylcompactin|Mevacor®
(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate
(1S,3R,7S,8S,8AR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyric acid
1 alpha-Isomer lovastatin
2b,6a-Dimethyl-8a-(2-methyl-1-oxobutoxy)-mevinate lactone
2b,6a-Dimethyl-8a-(2-methyl-1-oxobutoxy)-mevinic acid lactone
2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinate lactone
2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone
2β,6α-dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone
2Β,6α-dimethyl-8α-(2-methyl-1-oxobutoxy)-mevinate lactone
2Β,6α-dimethyl-8α-(2-methyl-1-oxobutoxy)-mevinic acid lactone
6 alpha-Methylcompactin
6 Methylcompactin
6-alpha-methylcompactin
6alpha-Methylcompactin
6a-Methylcompactin
6-Methylcompactin
6Α-methylcompactin
alpha-Isomer lovastatin, 1
Altocor
ALTOPREV
Artein
Belvas
C10AA02
Cholestra
Closterol
Colevix
Hipolip
Hipovastin
L-154803
Lestatin
Lipdip
Lipivas
Lipofren
|
Lovalip
Lovalord
Lovastatin
lovastatin lactone
Lovastatin, (1 alpha(s*))-isomer
Lovastatin, 1 alpha isomer
Lovastatin, 1 alpha-isomer
Lovastatina
Lovastatina [Spanish]
Lovastatine
Lovastatine [French]
Lovastatinum
Lovastatinum [Latin]
Lovasterol
Lovastin
Lozutin
Mevacor
MEVINACOR
MEVINACOR 10
MEVINACOR 40
Mevinolin
Mevlor
MK-803
ML-530b
Monacolin K
Nergadan
Paschol
Rodatin
Rovacor
SIMVASTATIN IMPURITY, LOVASTATIN-
Sivlor
Taucor
Tecnolip
Teroltrat
|
|
36 |
|
L 647318 |
|
Phase 2 |
|
|
|
37 |
|
Dihydromevinolin |
|
Phase 2 |
|
|
|
38 |
|
Antimetabolites |
|
Phase 2 |
|
|
|
39 |
|
Hypolipidemic Agents |
|
Phase 2 |
|
|
|
40 |
|
Anticholesteremic Agents |
|
Phase 2 |
|
|
|
41 |
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors |
|
Phase 2 |
|
|
|
42 |
|
Lipid Regulating Agents |
|
Phase 2 |
|
|
|
43 |
|
Oxytocin |
Approved, Vet_approved |
|
|
50-56-6 |
439302 53477758 |
Synonyms:
(2S)-2-[({1-[(4R,7S,10S,13S,16S,19R)-19-amino-13-[(2S)-butan-2-yl]-6,9,12,15,18-pentahydroxy-10-[2-(C-hydroxycarbonimidoyl)ethyl]-7-[(C-hydroxycarbonimidoyl)methyl]-16-[(4-hydroxyphenyl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carbonyl]pyrrolidin-2-yl}(hydroxy)methylidene)amino]-N-[(C-hydroxycarbonimidoyl)methyl]-4-methylpentanimidate
(Arg8)-vasopressin
(Arg8)-vasotocin
[<sup>3</sup>H]oxytocin
alpha-Hypophamine
Argipressin
Argpressin acetate
Biotinyl-(arg8)-vasopressin
Cys-tyr-ile-GLN-asn-cys-pro-arg-gly-NH2
Cys-tyr-ile-GLN-asn-cys-pro-leu-gly-NH2
Cys-tyr-ile-THR-asn-cys-gly-leu-gly-NH2
Cys-tyr-phe-GLN-asn-cys-pro-arg-gly-NH2
Cys-tyr-phe-GLN-asn-cys-pro-lys-gly-NH2
Disulfide bridge cys1-cys6
Gly-leu-pro-c
Ocytocin
|
ORASTHIN
Oxitocina
OXT
OXYTOCIN
Oxytocin 10 usp units in dextrose 5%
Oxytocin 20 usp units in dextrose 5%
Oxytocin 5 usp units in dextrose 5%
Oxytocin acetate
Oxytocin injection
PITOCIN
SID29217903
SID50111741
SYNTOCINON
SYNTOMETRINE
SYT670
TTA-121
|
|
44 |
|
Topiramate |
Approved |
|
|
97240-79-4 |
5284627 |
Synonyms:
[(1R,2S,6S,9R)-4,4,11,11-TETRAMETHYL-3,5,7,10,12-PENTAOXATRICYCLO[7.3.0.0^{2,6}]DODECAN-6-YL]METHYL SULFAMATE
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-b-D-fructopyranose sulphamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulphamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamic acid
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamate
2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulphamic acid
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulfamic acid
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamate
2,3:4,5-Di-O-isopropylidene-β-D-fructopyranose sulphamic acid
2,3-4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
|
Epitomax
epitomax|Eprontia® (liquid formulation)|MCN-4853|RWJ-17021|Topamax®
MCN-4853
QUDEXY XR
RWJ-17021
RWJ-17021-000
Tipiramate
Tipiramate [French]
Tipiramato
Tipiramato [Spanish]
Tipiramic acid
Topamax
Topamax sprinkle
TOPIRAMATE
topiramate tablet
Topiramato
Topiramato [INN-Spanish]
Topiramatum
Topiramatum [INN-Latin]
Topiramic acid
Topomax
TPM
Trokendi XR
USL255
USL-255
|
|
45 |
|
Sulfamethazine |
Approved, Investigational, Vet_approved |
|
|
57-68-1 |
5327 |
Synonyms:
(p-Aminobenzolsulfonyl)-2-amino-4,6-dimethylpyrimidin
(p-Aminobenzolsulphonyl)-2-amino-4,6-dimethylpyrimidin
2-(4-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine
2-(4-Aminobenzenesulphonamido)-4,6-dimethylpyrimidine
2-(p-Aminobenzenesulfonamido)-4,6-dimethylpyrimidine
2-(p-Aminobenzenesulphonamido)-4,6-dimethylpyrimidine
2-Sulfanilamido-4,6-dimethylpyrimidine
2-Sulphanilamido-4,6-dimethylpyrimidine
4,6-Dimethyl-2-sulfanilamidopyrimidine
4,6-Dimethyl-2-sulphanilamidopyrimidine
4-Amino-N-(2,6-dimethyl-4-pyrimidinyl)benzenesulfonamide
4-Amino-N-(2,6-dimethyl-4-pyrimidinyl)benzenesulphonamide
4-Amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide
4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulfonamide
4-Amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulphonamide
4-Amino-N-(4,6-dimethyl-pyrimidin-2-yl)-benzenesulphonamide
6-(4'-Aminobenzol-sulfonamido)-2,4-dimethylpyrimidin
6-(4'-Aminobenzol-sulphonamido)-2,4-dimethylpyrimidin
N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulfanilamide
N(1)-(4,6-Dimethyl-2-pyrimidinyl)sulphanilamide
N(1)-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide
N(1)-(4,6-Dimethyl-2-pyrimidyl)sulphanilamide
N-(4,6-Dimethyl-2-pyrimidyl)sulfanilamide
N-(4,6-Dimethyl-2-pyrimidyl)sulphanilamide
SMZ
|
SMZ-MED 454
Sulfadimethyldiazine
Sulfadimethylpyrimidine
Sulfadimezine
Sulfadimidina
Sulfadimidine
Sulfadimidinum
Sulfametazina
Sulfametazyny
SULFAMETHAZINE
SULFAMETHAZINE (TRISULFAPYRIMIDINES)
Sulfamethazone
Sulfamezathine
SULFAMEZATHINE ('S-MEZ')
Sulphadimethyldiazine
Sulphadimethylpyrimidine
Sulphadimidina
Sulphadimidine
Sulphadimidinum
Sulphametazina
Sulphametazyny
Sulphamethazine
Sulphamethazone
Sulphamezathine
|
|
46 |
|
Benzocaine |
Approved, Investigational |
|
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
47 |
|
Tannic acid |
Approved |
|
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
48 |
|
Aspartic acid |
Approved, Nutraceutical |
|
|
56-84-8 |
5960 |
Synonyms:
(+)-Aspartate
(+)-Aspartic acid
(+-)-Aspartic acid
(2S)-2-AMINOBUTANEDIOIC ACID
(2S)-2-AMINOSUCCINIC ACID
(2S)-Aspartate
(2S)-Aspartic acid
(L)-Aspartate
(L)-Aspartic acid
(R)-2-Aminosuccinate
(R,S)-Aspartic acid
(S)-(+)-Aspartate
(S)-(+)-Aspartic acid
(S)-2-Aminobutanedioate
(S)-2-Aminobutanedioic acid
(S)-2-Aminosuccinate
(S)-2-Aminosuccinic acid
(S)-Aminobutanedioate
(S)-Amino-butanedioate
(S)-Aminobutanedioic acid
(S)-Amino-butanedioic acid
(S)-Aspartate
(S)-Aspartic acid
[<sup>3</sup>H]-L-aspartate|[<sup>3</sup>H]-L-aspartic acid
2-Amino-3-methylsuccinate
2-Amino-3-methylsuccinic acid
2-Aminosuccinate
2-Aminosuccinic acid
ácido aspártico
Acidum asparticum
alpha-Aminosuccinate
alpha-Aminosuccinic acid
Aminosuccinate
Ammonium aspartate
Asp
Asparagate
Asparagic acid
Asparaginate
Asparaginic acid
Asparatate
ASPARTate
Aspartate magnesium hydrochloride
Aspartate, ammonium
Aspartate, calcium
Aspartate, dipotassium
Aspartate, disodium
Aspartate, magnesium
Aspartate, monopotassium
Aspartate, monosodium
Aspartate, potassium
Aspartate, sodium
|
ASPARTIC ACID
Aspartic acid, ammonium salt
Aspartic acid, calcium salt
Aspartic acid, dipotassium salt
Aspartic acid, disodium salt
Aspartic acid, hydrobromide
Aspartic acid, hydrochloride
Aspartic acid, magnesium (1:1) salt, hydrochloride, trihydrate
Aspartic acid, magnesium (2:1) salt
Aspartic acid, magnesium-potassium (2:1:2) salt
Aspartic acid, monopotassium salt
Aspartic acid, monosodium salt
Aspartic acid, potassium salt
Aspartic acid, sodium salt
Calcium aspartate
D
Dipotassium aspartate
Disodium aspartate
FEMA NO. 3656
H-Asp-OH
Hydrobromide aspartic acid
Hydrochloride aspartic acid
Hydrochloride, aspartate magnesium
L Aspartate
L Aspartic acid
L-(+)-Aspartate
L-(+)-Aspartic acid
L-Aminosuccinate
L-Aminosuccinic acid
L-Asp
L-Asp|L-aspartate
L-Asparagate
L-Asparagic acid
L-Asparaginate
L-Asparaginic acid
L-Asparaginsaeure
L-Asparaginsäure
L-Aspartate
L-Aspartic acid
Magnesiocard
Magnesium aspartate
MG 5 Longoral
MG5Longoral
MG-5-Longoral
Monopotassium aspartate
Monosodium aspartate
NSC-3973
Poly-DL-succinimide
Polysuccinimide
Potassium aspartate
Sodium aspartate
|
|
49 |
|
Anticonvulsants |
|
|
|
|
|
50 |
|
Hypoglycemic Agents |
|
|
|
|
|
Interventional clinical trials:
(show top 50)
(show all 57)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Aripiprazole Treatment for Antipsychotic Induced Hyperprolactinaemia in Patients With Severe Mental Illness and Learning Disabilities |
Completed |
NCT01085383 |
Phase 4 |
Aripiprazole |
2 |
An Open-Label Clinical Trial Conducted Via Telepsychiatry of Complementary and Alternative Treatments (Omega-3 Fatty Acids and Inositol vs. N-acetylcysteine) for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD) |
Recruiting |
NCT03757585 |
Phase 4 |
Open-label Treatment with Omega-3 Fatty Acids + Inositol;Open-label Treatment with N-acetylcysteine |
3 |
Enhancing Self-Understanding and Social Integration of Middle School Students With Learning Disabilities |
Unknown status |
NCT00246792 |
Phase 2, Phase 3 |
|
4 |
Multicenter Double-blind Placebo-Controlled Randomized Clinical Trial of Efficacy and Safety of Tenoten for Children in the Treatment of Specific Developmental Disorders of Scholastic Skills in Children |
Completed |
NCT03159104 |
Phase 3 |
Tenoten for children;Placebo |
5 |
Prospective Trial of Risperdal (Risperidone) Following Psychological Therapy for Challenging Behaviour in Learning Disabled Children |
Completed |
NCT00254930 |
Phase 3 |
risperidone |
6 |
Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions: A Randomized-controlled Trial |
Recruiting |
NCT03553875 |
Phase 3 |
Memantine Hydrochloride;Placebo |
7 |
Building Complex Language: Effect of Treatment and Dosage |
Completed |
NCT01337232 |
Phase 1, Phase 2 |
|
8 |
Neurobiology and Treatment of Reading Disability in NF1 |
Recruiting |
NCT02964884 |
Phase 2 |
Lovastatin;Placebo Oral Tablet |
9 |
Sensitivity of the Search for a Heterophory-Vertical-Labile (HV-Labile) for Ambulatory Screening for Specific Learning Disabilities (SLD) or Developmental Coordination Disorder (DCD). |
Unknown status |
NCT04122820 |
|
|
10 |
Move and Feel Good : Effects of Intensive Physical Training on Brain Plasticity, Cognition and Psychological Well-being. "Effets de l'entraînement Physique Intensif Sur la plasticité cérébrale, la Cognition et le Bien être Psychologique". |
Unknown status |
NCT02970825 |
|
|
11 |
Complex Motor Learning With Motor Imaginary |
Unknown status |
NCT02999516 |
|
|
12 |
The Effects of Intranasal Oxytocin on Reward Sensitivity and Performance Monitoring During Reinforcement Learning: an ERP Study |
Unknown status |
NCT03846271 |
|
intranasal oxytocin;intranasal placebo |
13 |
The Contribution of Risk and Resilience Factors in Learning Disabilities Population to Academic and Emotional Development |
Unknown status |
NCT01652651 |
|
|
14 |
Effects of the Periodic Application of in Situ Simulation in Cardiopulmonary Resuscitation: Randomized Controlled Trial. |
Unknown status |
NCT03626272 |
|
|
15 |
Efficacy of the MovinCog Intervention in Children: A Randomized, Placebo-controlled Trial |
Unknown status |
NCT03255499 |
|
|
16 |
Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational Study |
Unknown status |
NCT00956696 |
|
topiramate |
17 |
The Additive Effect of Cognitive Behavioral Treatment - CBT to Conventional Weight Loss Intervention Program for Young Adults With Intellectual Disabilities |
Unknown status |
NCT01032369 |
|
|
18 |
Efficacy and Safety of Memantine Hydrochloride, a Low Affinity Antagonist to N-Methyl-D-Aspartate (NMDA) Type Receptors, in the Prevention of Cognitive Decline and Disease Progression in Down's Syndrome |
Unknown status |
NCT00240760 |
|
Memantine Hydrochloride |
19 |
The Becoming of Children With Doose Syndrome |
Unknown status |
NCT04048213 |
|
|
20 |
Teacher Help: Novel Technologies for Meeting the Immediate Needs of Youth With Mental Health Disorders in Canada |
Unknown status |
NCT02919215 |
|
|
21 |
Computerized Eye-tracking Attention Training for Children With Special Needs |
Completed |
NCT04178421 |
|
|
22 |
Assessment of the Diagnostic Approach to Specific Language Disorders and Learning Using a New Calibrated Tool: the Modular Battery Tests Computerized (BMTi) |
Completed |
NCT03919357 |
|
|
23 |
Affective Learning in Disabled Health Training of Turkish Nursing Students: A Randomized Controlled Study |
Completed |
NCT04365894 |
|
|
24 |
Efficacy of Using Augmentative Alternative Communication for Functional Communication in Group Activities |
Completed |
NCT04583332 |
|
|
25 |
A Computerised Test for Assessing the Early Reading Skills of Children With Mobility Limitations |
Completed |
NCT02797301 |
|
|
26 |
Development of a Resiliency Training Program for Parents of Children With Specific Learning Disabilities |
Completed |
NCT02772432 |
|
|
27 |
Learning Disabilities: Links to Schools and Biology |
Completed |
NCT00061412 |
|
|
28 |
Effectiveness of Visual Pedagogy-assisted Tooth-brushing Training Among Preschoolers With Special Needs for Oral Health Promotion |
Completed |
NCT03522337 |
|
|
29 |
A Mixed Methods Study to Design and Test Effectiveness of a Psycho-social Training Intervention on Psychological Health of Parents for Intellectually Disabled Children in Malawi |
Completed |
NCT02827396 |
|
|
30 |
Investigation of Lycra Splinting Garments for Falls and Intellectual Disabilities |
Completed |
NCT02345512 |
|
|
31 |
Effects Of A Computerized Working Memory Training Program On Attention, Working Memory, And Academics, In Adolescents With Severe ADHD/LD |
Completed |
NCT00930449 |
|
|
32 |
INVESTIGATION OF HAND FUNCTIONS IN CHILDREN WITH SPECIFIC LEARNING DISORDER |
Completed |
NCT05319197 |
|
|
33 |
Screening for Glucose Intolerance and Development of a Lifestyle Education Programme for Prevention of Type 2 Diabetes in a Population With Learning Disabilities |
Completed |
NCT02513277 |
|
|
34 |
Assessment of a Drama Workshop Program for Immigrant and Refugee Adolescents |
Completed |
NCT01426451 |
|
|
35 |
Effects of a Task Oriented Intervention for Children With Disabilities, Based on Children's or Parent's Goals, a Randomized Study. |
Completed |
NCT02160886 |
|
|
36 |
Using New Genetic Technology to Diagnose Neurodevelopmental Disorders |
Completed |
NCT02227381 |
|
|
37 |
Application of a Training Program for Executive Functions in a Sample of Egyptian Children With Learning Disorder |
Completed |
NCT05476133 |
|
|
38 |
The Efficacy of Using Volunteers to Implement a Cognitive Stimulation Program in Two Long-Term Care Homes |
Completed |
NCT01818778 |
|
|
39 |
Effects of a Web-based Training Programme for Professional Carers Working With People With Learning Disabilities Who Exhibit Challenging Behaviour |
Completed |
NCT03390868 |
|
|
40 |
Clinical and Cost Effectiveness of a Parent Mediated Intervention to Reduce Challenging Behaviour in Pre-schoolers With Moderate to Severe Learning Disability: a Randomised Controlled Trial |
Completed |
NCT03086876 |
|
|
41 |
Integrating Attention and Self-Regulation Into an Intensive Intervention for Middle School English Learners With Persistent Reading Difficulties |
Recruiting |
NCT03695068 |
|
|
42 |
An Alternative Perspective to Comprehend Handwriting Performance: Development and Applications of a Biomechanical Assessment and Biofeedback-training System for Handwriting (BABSH) |
Recruiting |
NCT03822702 |
|
|
43 |
Improving STEM Outcomes for Young Children With Language Learning Disabilities by Intervening at the Intersection of Language and Scientific Thought: A Telehealth RCT |
Recruiting |
NCT04775199 |
|
|
44 |
Childhood Learning and Executive Function Disorders and Risk of Psychosis in the Adulthood |
Recruiting |
NCT04280367 |
|
|
45 |
Low Intensity Focused Ultrasound of Medial Temporal Lobe Regions for the Improvement of Learning and Memory |
Recruiting |
NCT03717922 |
|
|
46 |
Toileting Assessment and Toilet Training for Adults With Learning Disabilities With Incontinence |
Recruiting |
NCT05626062 |
|
|
47 |
Impact of Repetitive Transcranial Magnetic Stimulation (TMS) on Spike Frequency and Brain Connectivity in Children With Benign Epilepsy With Centrotemporal Spike (BECTS) |
Recruiting |
NCT04325282 |
|
|
48 |
Gait Parameters Under Single and Dual Task Conditions in Children With Specific Learning Difficulties: A Case-control Study |
Recruiting |
NCT04783987 |
|
|
49 |
Severe LD in Juvenile Delinquents: Presentation, Course, and Remediation |
Recruiting |
NCT03261076 |
|
|
50 |
Effect of Music and Rhythm Training Delivered Through a Serious Game on the Reading Skills of Children With a Specific Learning Disorder Impacting Reading, a Multicentric Double-blind and Placebo-controlled Study (Mila-Learn-01) |
Recruiting |
NCT05154721 |
|
|
|